ALXO ALX Oncology Holdings Inc. - Common Stock
$2.03
가격 · 8월 18, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$1–$3
66% of range
애널리스트 평점
BUY
13 analysts
목표 주가
$5
+127% upside
P/E (TTM)
-2.7
ROE
-225.0%
순이익률
—
ALXO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$2.03
시가총액
$280M
P/E (TTM)
-2.7
EPS (TTM)
$-1.90
매출 (TTM)
—
배당 수익률
—
ROE
-225.0%
부채/자본
0.4
52주 범위
$1 – $3
ALXO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
2018-12-31
→
2022-12-31
EPS
$-1.90
2020-12-31
→
2025-12-31
잉여현금흐름
$-84M
2020-12-31
→
2025-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
ALXO
동종업계 중앙값
P/E (TTM)
-2.7
—
P/S (TTM)
75.0
50.2
P/B
10.8
1.0
EV / EBITDA
-2.4
—
Price / FCF (주가 / FCF)
-3.3
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
ALXO
동종업계 중앙값
ROA
-98.3%
-40.4%
ROE
-225.0%
-43.7%
ROIC
-291.1%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
ALXO
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
0.4
0.0
Current Ratio (유동비율)
2.1
7.3
Quick Ratio (당좌 비율)
1.8
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
ALXO
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
ALXO
동종업계 중앙값
ALXO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
13 명의 애널리스트
- 적극 매수 3 23.1%
- 매수 8 61.5%
- 보유 2 15.4%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
5 명의 애널리스트 · 2026-08-17
중앙값
$4.00
평균
$4.60
← 모든 목표가 하회
$2.03
저가
$4.00
고가
$6.00
중앙값 목표
$4.00
+97.4%
평균 목표
$4.60
+127.0%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.12 | $-0.15 | 0.03% |
| 2026년 3월 31일 | $-0.15 | $-0.20 | 0.05% |
| 2025년 12월 31일 | $-0.37 | $-0.37 | -0.00% |
| 2025년 9월 30일 | $-0.41 | $-0.37 | -0.04% |
| 2025년 6월 30일 | $-0.43 | $-0.46 | 0.03% |
| 2025년 3월 31일 | $-0.58 | $-0.47 | -0.11% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
| SRZN | — | — | — | — | — | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| ZSQR | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | $1M | $5M | |
| R&D Expense | $77M | $116M | $142M | $98M | $60M | $29M | $16M | |
| SG&A Expense | $24M | $26M | $28M | $29M | $23M | $15M | $3M | |
| Operating Expenses | $104M | $142M | $170M | $127M | $84M | $45M | $24M | |
| Operating Income | $-104M | $-142M | $-170M | $-127M | $-84M | $-44M | $-19M | |
| Interest Expense | $2M | $2M | $2M | $238.0K | $13.0K | · | · | |
| Interest Income | $4M | $9M | $11M | $4M | $91.0K | · | · | |
| Other Non-op | $-36.0K | $-20.0K | $389.0K | $-22.0K | $-7.0K | $-1M | $-5.0K | |
| Pretax Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-45M | $-19M | |
| Income Tax | $0 | $0 | $0 | $64.0K | $-21.0K | $241.0K | $34.0K | |
| Net Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | $-19M | |
| EPS (Basic) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| Shares (Basic) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | 3,076,461 | |
| Shares (Diluted) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | · | |
| EBITDA | $-103M | $-142M | $-169M | $-127M | $-84M | $-43M | · |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $22M | $49M | $364M | $434M | $9M | |
| Short-term Investments | $28M | $110M | $160M | $217M | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $5M | $3M | $2M | $256.0K | |
| Other Current Assets | $20.0K | $27.0K | $439.0K | · | · | · | · | |
| Current Assets | $51M | $134M | $189M | $271M | $367M | $436M | $10M | |
| PP&E (Net) | $1M | $3M | $4M | $4M | $897.0K | $52.0K | $860.0K | |
| PP&E (Gross) | $3M | $5M | $5M | $4M | $960.0K | $77.0K | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $403.0K | $63.0K | $25.0K | $1M | |
| Other Non-current Assets | $4M | $7M | $15M | $15M | $12M | $10.0K | $7.0K | |
| Total Assets | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Accounts Payable | $5M | $4M | $9M | $8M | $4M | $4.0K | $4M | |
| Current Liabilities | $25M | $18M | $36M | $28M | $15M | $6M | $5M | |
| Capital Leases | $3M | $3M | $4M | $5M | $2M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $5M | $2M | $5.0K | $547.0K | |
| Total Liabilities | $33M | $34M | $53M | $43M | $17M | $6M | $11M | |
| Long-term Debt | $10M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | |
| Retained Earnings | $-723M | $-621M | $-486M | $-325M | $-202M | $-119M | $-73M | |
| AOCI | $28.0K | $275.0K | $256.0K | $-845.0K | · | · | · | |
| Stockholders' Equity | $26M | $114M | $190M | $263M | $363M | $430M | $-71M | |
| Liabilities + Equity | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Shares Outstanding | 54,388,022 | 53,052,912 | 49,951,989 | 40,861,386 | 40,587,067 | 39,844,522 | 3,166,946 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | |
| Stock-based Comp | $13M | $27M | $26M | $24M | $14M | $5M | $297.0K | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $4M | $-15M | $3M | $10M | $1M | $2M | · | |
| Operating Cash Flow | $-84M | $-122M | $-130M | $-89M | $-68M | $-38M | $-14M | |
| CapEx | $212.0K | $447.0K | $1M | $1M | $666.0K | $31.0K | $353.0K | |
| Investing Cash Flow | $83M | $86M | $45M | $-235M | $-5M | $610.0K | $-353.0K | |
| Stock Issued | $2M | $30M | · | · | · | $368M | · | |
| Net Stock Activity | $2M | $30M | · | · | · | $368M | · | |
| Financing Cash Flow | $362.0K | $31M | $59M | $10M | $2M | $463M | $15M | |
| Free Cash Flow | $-84M | $-122M | $-132M | $-91M | $-69M | $-38M | · | |
| Levered FCF | $-86M | · | · | · | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -3694.0% | · | |
| Net Margin | · | · | · | · | · | -3869.7% | · | |
| Pretax Margin | · | · | · | · | · | -3849.3% | · | |
| EBITDA Margin | · | · | · | · | · | -3676.9% | · | |
| ROA | -98.3% | -69.1% | -58.6% | -36.0% | -20.4% | -20.5% | · | |
| ROE | -225.0% | -107.7% | -89.7% | -44.9% | -22.3% | -13.4% | · | |
| ROIC | -291.1% | · | · | -46.7% | -23.0% | -10.2% | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 | 70.3 | · | |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 | 70.0 | · | |
| Debt / Equity | 0.4 | 0.1 | 0.1 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Interest Coverage | -64.9 | -82.4 | -108.8 | · | · | · | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | 0.0 | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $4M | $0 | $0 | $1M | · | |
| Net Income TTM | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | · | |
| Market Cap | $61M | $89M | $744M | $461M | $872M | $3.43B | · | |
| Enterprise Value | $26M | $-29M | $571M | $204M | · | · | · | |
| P/E | -0.6 | -0.6 | -4.0 | -3.7 | -10.4 | -31.2 | · | |
| P/S | 16.5 | 23.7 | 199.2 | · | · | 2905.8 | · | |
| P/B | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Tangible Book | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Cash Flow | -0.7 | -0.7 | -5.7 | -5.2 | -12.8 | -89.7 | · | |
| P / FCF | -0.7 | -0.7 | -5.7 | -5.1 | -12.7 | -89.6 | · | |
| EV / EBITDA | -0.3 | 0.2 | -3.4 | -1.6 | · | · | · | |
| EV / FCF | -0.3 | 0.2 | -4.3 | -2.2 | · | · | · | |
| EV / Revenue | 7.1 | -7.8 | 152.9 | · | · | · | · | |
| Earnings Yield | -168.1% | -154.5% | -25.1% | -26.9% | -9.6% | -3.2% | · |
손익계산서 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $14M | $18M | $17M | $18M | $24M | $24M | $26M | $35M | $32M | $42M | $46M | $29M | $25M | $25M | $29M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $7M | $6M | $6M | $8M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $18M | $19M | $23M | $23M | $27M | $32M | $31M | $33M | $42M | $38M | $48M | $53M | $37M | $32M | $32M | $37M | |
| Operating Income | $-18M | $-19M | $-23M | $-23M | $-27M | $-32M | $-31M | $-33M | $-42M | $-38M | $-48M | $-53M | $-37M | $-32M | $-32M | $-37M | |
| Interest Expense | $285.0K | $331.0K | $383.0K | $408.0K | $405.0K | $406.0K | $427.0K | $446.0K | $429.0K | $427.0K | $415.0K | $391.0K | $372.0K | $387.0K | $231.0K | $2.0K | |
| Interest Income | $2M | $1M | $573.0K | $802.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Other Non-op | $-257.0K | $188.0K | $-17.0K | $-6.0K | $-2.0K | $-11.0K | $-1.0K | $3.0K | $-8.0K | $-14.0K | $-29.0K | $-1.0K | $324.0K | $95.0K | $-2.0K | $-7.0K | |
| Net Income | $-18M | $-18M | $-23M | $-22M | $-26M | $-31M | $-29M | $-31M | $-39M | $-36M | $-45M | $-51M | $-34M | $-30M | $-31M | $-35M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-0.92 | $-1.24 | $-0.84 | $-0.74 | $-0.75 | $-0.87 | |
| Shares (Basic) | 135,639,684 | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | |
| Shares (Diluted) | 135,639,684 | 104,573,657 | -106,723,636 | 53,577,066 | 53,445,631 | 53,359,338 | -102,470,889 | 52,693,878 | 51,831,157 | 50,120,758 | -79,898,141 | 41,147,938 | 40,875,457 | 40,862,513 | -81,351,467 | 40,747,026 | |
| EBITDA | $-18M | $-19M | · | $-23M | $-27M | $-32M | · | $-33M | $-42M | $-38M | · | $-53M | $-37M | $-32M | · | $-37M |
대차대조표 23
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $32M | $16M | $23M | $19M | $21M | $18M | $16M | $16M | $14M | $22M | $20M | $38M | $63M | $49M | $49M | |
| Short-term Investments | $116M | $108M | $28M | $37M | $60M | $77M | $110M | $132M | $141M | $143M | · | $170M | $175M | $165M | · | $236M | |
| Prepaid Expense | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $12M | $10M | · | $9M | $7M | $5M | · | $6M | |
| Other Current Assets | $542.0K | $25.0K | $20.0K | · | $4.0K | · | $27.0K | $1M | $315.0K | · | · | · | · | · | · | · | |
| Current Assets | $143M | $146M | $51M | $67M | $85M | $103M | $134M | $156M | $169M | $168M | · | $199M | $220M | $233M | · | $291M | |
| PP&E (Net) | $166.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $2M | |
| PP&E (Gross) | $1M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $3M | |
| Accum. Depreciation | $938.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $823.0K | $616.0K | · | $300.0K | |
| Other Non-current Assets | $2M | $3M | $4M | $9M | $4M | $7M | $7M | $13M | $13M | $14M | · | $11M | $11M | $13M | · | $16M | |
| Total Assets | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | |
| Accounts Payable | $3M | $4M | $5M | $7M | $5M | $4M | $4M | $8M | $8M | $6M | · | $13M | $4M | $10M | · | $6M | |
| Current Liabilities | $15M | $20M | $25M | $28M | $19M | $19M | $18M | $32M | $38M | $32M | · | $35M | $18M | $22M | · | $25M | |
| Capital Leases | $0 | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $152.0K | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | · | $7M | $6M | $6M | · | $5M | |
| Total Liabilities | $25M | $27M | $33M | $38M | $31M | $33M | $34M | $49M | $55M | $48M | · | $51M | $33M | $38M | · | $31M | |
| Long-term Debt | $10M | $9M | $10M | $11M | $11M | $11M | $10M | $11M | $11M | $11M | · | $11M | $11M | $11M | · | · | |
| Total Debt | $10M | $9M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | $10M | $10M | $9M | · | · | |
| Common Stock | $138.0K | $135.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $52.0K | $50.0K | · | $41.0K | $41.0K | $41.0K | · | $41.0K | |
| Retained Earnings | $-759M | $-741M | $-723M | $-700M | $-678M | $-652M | $-621M | $-592M | $-561M | $-522M | · | $-441M | $-390M | $-356M | · | $-295M | |
| AOCI | $-224.0K | $-245.0K | $28.0K | $43.0K | $36.0K | $118.0K | $275.0K | $563.0K | $-73.0K | $28.0K | · | $-226.0K | $-312.0K | $-88.0K | · | $-2M | |
| Stockholders' Equity | $136M | $151M | $26M | $45M | $64M | $88M | $114M | $137M | $159M | $164M | $190M | $169M | $213M | $240M | $263M | $287M | |
| Liabilities + Equity | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | · | $220M | $246M | $278M | · | $318M | |
| Shares Outstanding | 138,216,247 | 134,540,741 | 54,388,022 | 53,577,566 | 53,506,777 | 53,384,145 | 53,052,912 | 52,743,104 | 52,452,749 | 50,277,193 | · | 41,151,819 | 40,992,179 | 40,863,049 | · | 40,748,290 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $86.0K | $150.0K | $151.0K | $153.0K | $191.0K | $211.0K | $214.0K | $224.0K | $220.0K | $214.0K | $207.0K | $209.0K | $207.0K | $213.0K | $105.0K | $95.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-cash | · | $-3M | · | · | · | $664.0K | · | · | · | $-10M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-16M | $-19M | $-19M | $-17M | $-23M | $-25M | $-32M | $-25M | $-27M | $-38M | $-40M | $-31M | $-32M | $-28M | $-21M | $-31M | |
| CapEx | $17.0K | $50.0K | $49.0K | $56.0K | $47.0K | $60.0K | $60.0K | $149.0K | $90.0K | $148.0K | $148.0K | $-1M | $2M | $690.0K | $389.0K | $192.0K | |
| Investing Cash Flow | $7M | $-105M | $11M | $21M | $22M | $28M | $33M | $26M | $907.0K | $26M | $-17M | $13M | $6M | $42M | $11M | $14M | |
| Stock Issued | $0 | $11.0K | $1M | $0 | $0 | $372.0K | $359.0K | $75.0K | $26M | $3M | · | · | · | · | · | · | |
| Net Stock Activity | · | $11.0K | · | · | · | $372.0K | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $137.0K | $140M | $678.0K | $-159.0K | $-222.0K | $65.0K | $328.0K | $251.0K | $27M | $3M | $59M | $-111.0K | $343.0K | $-107.0K | $9M | $-136.0K | |
| Free Cash Flow | · | $-19M | · | · | · | $-25M | · | · | · | $-38M | · | · | · | $-29M | · | · |
수익성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.0% | -12.0% | · | -16.5% | -16.7% | -18.4% | · | -15.1% | -17.1% | -14.5% | · | -19.0% | -11.5% | -9.4% | · | -9.8% | |
| ROE | -17.9% | -15.0% | · | -24.4% | -23.2% | -24.4% | · | -20.1% | -21.2% | -17.6% | · | -22.4% | -12.9% | -10.3% | · | -10.5% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 7.2 | · | 2.4 | 4.5 | 5.5 | · | 4.8 | 4.4 | 5.2 | · | 5.7 | 12.5 | 10.6 | · | 11.5 | |
| Quick Ratio | 9.4 | 7.0 | · | 2.2 | 4.2 | 5.2 | · | 4.6 | 4.1 | 4.9 | · | 5.4 | 12.1 | 10.4 | · | 11.3 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | |
| Interest Coverage | -63.3 | -57.3 | · | -55.2 | -65.8 | -78.4 | · | -73.0 | -96.8 | -88.4 | · | -136.3 | -98.9 | -83.2 | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Net Income TTM | $-84M | $-97M | · | $-110M | $-127M | $-136M | · | $-157M | $-160M | $-151M | · | $-151M | $-133M | $-123M | · | $-117M | |
| Market Cap | $286M | $270M | · | $98M | $22M | $33M | · | $96M | $316M | $561M | · | $198M | $308M | $185M | · | $390M | |
| Enterprise Value | $158M | $138M | · | $48M | $-47M | $-55M | · | $-43M | $169M | $413M | · | $17M | $105M | $-34M | · | · | |
| P/E | -1.7 | -1.2 | · | -0.9 | -0.2 | -0.2 | · | -0.6 | -1.7 | -3.2 | · | -1.3 | -2.3 | -1.5 | · | -3.3 | |
| P/S | 76.6 | 72.3 | · | 26.3 | 5.9 | 8.9 | · | 25.7 | 84.7 | 150.2 | · | 52.9 | 82.5 | 49.5 | · | 104.5 | |
| P/B | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | |
| P / Tangible Book | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | · | 1.2 | 1.4 | 0.8 | · | 1.4 | |
| P / Cash Flow | · | -14.5 | · | · | · | -1.3 | · | · | · | -14.8 | · | · | · | -6.6 | · | · | |
| P / FCF | · | -14.4 | · | · | · | -1.3 | · | · | · | -14.7 | · | · | · | -6.5 | · | · | |
| EV / EBITDA | -8.7 | -7.3 | · | -2.1 | 1.8 | 1.7 | · | 1.3 | -4.1 | -11.0 | · | -0.3 | -2.8 | 1.1 | · | · | |
| EV / FCF | · | -7.4 | · | · | · | 2.2 | · | · | · | -10.8 | · | · | · | 1.2 | · | · | |
| EV / Revenue | 42.2 | 37.0 | · | 12.7 | -12.6 | -14.6 | · | -11.5 | 45.4 | 110.6 | · | 4.6 | 28.0 | -9.1 | · | · | |
| Earnings Yield | -58.0% | -82.3% | · | -112.6% | -580.7% | -422.1% | · | -180.8% | -58.9% | -31.7% | · | -76.9% | -43.4% | -66.8% | · | -30.2% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | — | — | — | $0 | $0 |
| 순이익 | $-102M | $-135M | $-161M | $-123M | $-83M |
| 희석 EPS | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.4 | 0.1 | 0.1 | 0.0 | — |
| 유동비율 | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 |
| 당좌 비율 | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-84M | $-122M | $-132M | $-91M | $-69M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 102개의 제출자 · $188.1M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 43 (+23 이전 분기 대비) | 11 (+1 이전 분기 대비) | 21 (+3 이전 분기 대비) | 13 (0 이전 분기 대비) | +11.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $26,934,527 | 13,011,849 | 14.32% | 주식 |
| venBio Partners LLC | $26,671,201 | 12,884,638 | 14.18% | 주식 |
| Redmile Group, LLC | $15,302,483 | 7,392,504 | 8.13% | 주식 |
| Blackstone Inc. | $13,648,634 | 6,593,543 | 7.26% | 주식 |
| Driehaus Capital Management LLC | $12,472,247 | 6,025,240 | 6.63% | 주식 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $11,891,647 | 5,744,757 | 6.32% | 주식 |
| TCG Crossover Management, LLC | $11,706,858 | 5,655,487 | 6.22% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,295,013 | 4,973,436 | 5.47% | 주식 |
| Vivo Capital, LLC | $6,592,356 | 3,184,713 | 3.50% | 주식 |
| 5AM Venture Management, LLC | $6,328,663 | 3,057,325 | 3.36% | 주식 |
| Almitas Capital LLC | $6,082,552 | 2,938,431 | 3.23% | 주식 |
| ORBIMED ADVISORS LLC | $5,933,150 | 2,866,256 | 3.15% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $4,900,930 | 2,367,377 | 2.61% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $4,508,824 | 2,178,176 | 2.40% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $3,195,240 | 1,543,594 | 1.70% | 주식 |
| STATE STREET CORP | $3,102,733 | 1,498,905 | 1.65% | 주식 |
| Ensign Peak Advisors, Inc | $1,677,315 | 810,297 | 0.89% | 주식 |
| VANGUARD GROUP INC | $1,607,644 | 1,422,694 | 0.85% | 주식 |
| Nantahala Capital Management, LLC | $1,552,500 | 750,000 | 0.83% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,550,904 | 749,229 | 0.82% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,539,026 | 743,491 | 0.82% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $1,249,860 | 603,797 | 0.66% | 주식 |
| ADAR1 Capital Management, LLC | $1,104,676 | 533,660 | 0.59% | 주식 |
| UBS Group AG | $894,341 | 432,049 | 0.48% | 주식 |
| TWO SIGMA ADVISERS, LP | $802,752 | 710,400 | 0.43% | 주식 |
| GOLDMAN SACHS GROUP INC | $644,037 | 311,129 | 0.34% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $499,104 | 241,113 | 0.27% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $467,969 | 226,072 | 0.25% | 주식 |
| Atom Investors LP | $454,121 | 219,382 | 0.24% | 주식 |
| IEQ CAPITAL, LLC | $363,041 | 175,382 | 0.19% | 주식 |
| Nuveen, LLC | $297,345 | 143,645 | 0.16% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $254,935 | 123,157 | 0.14% | 주식 |
| RHUMBLINE ADVISERS | $223,350 | 107,902 | 0.12% | 주식 |
| WELLS FARGO & COMPANY/MN | $203,742 | 98,426 | 0.11% | 주식 |
| Verdad Advisers, LP | $170,154 | 82,200 | 0.09% | 주식 |
| BANK OF AMERICA CORP /DE/ | $157,386 | 76,032 | 0.08% | 주식 |
| Graham Capital Management, L.P. | $154,879 | 74,821 | 0.08% | 주식 |
| BlackRock, Inc. | $146,579 | 70,811 | 0.08% | 주식 |
| XTX Topco Ltd | $144,190 | 69,657 | 0.08% | 주식 |
| MetLife Investment Management, LLC | $134,465 | 64,959 | 0.07% | 주식 |
| Bank of New York Mellon Corp | $129,176 | 62,404 | 0.07% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $102,842 | 49,682 | 0.05% | 주식 |
| Nuveen Asset Management, LLC | $101,528 | 60,795 | 0.05% | 주식 |
| Squarepoint Ops LLC | $97,019 | 46,869 | 0.05% | 주식 |
| CITIGROUP INC | $91,925 | 44,408 | 0.05% | 주식 |
| Vanguard Global Advisers, LLC | $89,089 | 43,038 | 0.05% | 주식 |
| Invesco Ltd. | $89,064 | 43,026 | 0.05% | 주식 |
| AXQ CAPITAL, LP | $83,945 | 40,553 | 0.04% | 주식 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $80,773 | 38,011 | 0.04% | 주식 |
| CITADEL ADVISORS LLC | $74,934 | 36,200 | 0.04% | 콜 옵션 |
| NEW YORK STATE COMMON RETIREMENT FUND | $68,517 | 33,100 | 0.04% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $65,872 | 31,822 | 0.04% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $64,164 | 30,997 | 0.03% | 주식 |
| BARCLAYS PLC | $52,963 | 25,586 | 0.03% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $52,812 | 26,340 | 0.03% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $52,799 | 25,507 | 0.03% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51,336 | 24,800 | 0.03% | 콜 옵션 |
| HC Advisors, LLC | $47,403 | 22,900 | 0.03% | 주식 |
| Callan Family Office, LLC | $46,407 | 22,419 | 0.02% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $44,424 | 21,461 | 0.02% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $44,368 | 21,434 | 0.02% | 주식 |
| CAXTON CORP | $43,358 | 20,946 | 0.02% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $40,208 | 19,424 | 0.02% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $38,190 | 18,451 | 0.02% | 주식 |
| Bronte Capital Management Pty Ltd. | $37,457 | 18,095 | 0.02% | 주식 |
| JSF Financial, LLC | $36,225 | 17,500 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $34,942 | 16,880 | 0.02% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $34,395 | 16,616 | 0.02% | 주식 |
| PRUDENTIAL FINANCIAL INC | $33,917 | 16,385 | 0.02% | 주식 |
| MARSHALL WACE, LLP | $32,317 | 15,612 | 0.02% | 주식 |
| MONETA GROUP INVESTMENT ADVISORS LLC | $31,456 | 15,196 | 0.02% | 주식 |
| ProShare Advisors LLC | $29,238 | 14,125 | 0.02% | 주식 |
| Lido Advisors, LLC | $27,365 | 13,220 | 0.01% | 주식 |
| FMR LLC | $27,183 | 13,132 | 0.01% | 주식 |
| Abel Hall, LLC | $26,353 | 12,731 | 0.01% | 주식 |
| China Universal Asset Management Co., Ltd. | $25,875 | 12,500 | 0.01% | 주식 |
| Point72 Asia (Singapore) Pte. Ltd. | $25,449 | 13,907 | 0.01% | 주식 |
| Beacon Pointe Advisors, LLC | $25,063 | 12,500 | 0.01% | 주식 |
| Legal & General Group Plc | $21,700 | 10,483 | 0.01% | 주식 |
| HSBC HOLDINGS PLC | $21,574 | 10,105 | 0.01% | 주식 |
| Tower Research Capital LLC (TRC) | $21,522 | 10,397 | 0.01% | 주식 |
| XPONANCE LLC | $21,071 | 10,179 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $20,269 | 9,792 | 0.01% | 주식 |
| Russell Investments Group, Ltd. | $17,859 | 8,628 | 0.01% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $16,943 | 8,185 | 0.01% | 주식 |
| Cubist Systematic Strategies, LLC | $14,687 | 8,025 | 0.01% | 주식 |
| ROYAL BANK OF CANADA | $7,000 | 3,494 | 0.00% | 주식 |
| DEUTSCHE BANK AG\ | $4,324 | 2,089 | 0.00% | 주식 |
| ACADIAN ASSET MANAGEMENT LLC | $2,713 | 1,313,490 | 0.00% | 주식 |
| NISA INVESTMENT ADVISORS, LLC | $2,289 | 1,106 | 0.00% | 주식 |
| Bradley & Co. Private Wealth Management, LLC | $2,070 | 1,000 | 0.00% | 주식 |
| EverSource Wealth Advisors, LLC | $1,873 | 905 | 0.00% | 주식 |
| GSA CAPITAL PARTNERS LLP | $856 | 413,545 | 0.00% | 주식 |
| Sterling Capital Management LLC | $785 | 379 | 0.00% | 주식 |
| Integrated Wealth Concepts LLC | $270 | 130 | 0.00% | 주식 |
| MORGAN STANLEY | $242 | 117 | 0.00% | 주식 |
| JPMORGAN CHASE & CO | $218 | 99 | 0.00% | 주식 |
| PNC Financial Services Group, Inc. | $207 | 100 | 0.00% | 주식 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $186 | 89,779 | 0.00% | 주식 |
| CWM, LLC | $130 | 65 | 0.00% | 주식 |
회사 내부자 19 명의 내부자 · 10 임원 · 11 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | 2026년 8월 17일 S | 294,379 | 2 | 3 | $66,858 |
| Harish Shantharam | Chief Financial Officer | 2026년 1월 26일 A | 75,000 | 1 | 0 | $58,500 |
| Peter S Garcia | Chief Financial Officer | 2023년 12월 29일 S | 85,348 | 0 | 0 | $0 |
| Jaume Pons | President & CSO | 2023년 12월 29일 S | 618,359 | 0 | 0 | $0 |
| Shelly Pinto | SVP, FINANCE AND CAO | 2026년 8월 17일 S | 87,828 | 0 | 6 | $-11,961 |
| Jeff E. Knight | Chief Dev & Operating Officer | 2026년 4월 16일 A | — | 0 | 0 | $0 |
| Barbara Klencke | Chief Medical Officer | 2026년 4월 16일 A | — | 0 | 0 | $0 |
| Sophia Randolph | Chief Medical Officer | 2023년 12월 29일 S | 312,349 | 0 | 0 | $0 |
| Nathan Caffo | Chief Business Officer | 2020년 7월 21일 C | 11,254 | 0 | 0 | $0 |
| Steffen Pietzke | VP Fin & Chief Acct Officer | 2020년 7월 21일 P | 3,000 | 0 | 0 | $0 |
| Daniel J. Curran | 이사 | 2026년 1월 20일 A | — | 0 | 0 | $0 |
| Alan B. Sandler | 이사 | 2026년 1월 20일 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | 이사 | 2026년 1월 20일 A | 3,000 | 0 | 0 | $0 |
| Chris H Takimoto | 이사 | 2026년 1월 20일 A | — | 0 | 0 | $0 |
| Scott J. Garland | 이사 | 2026년 1월 20일 A | — | 0 | 0 | $0 |
| Itziar Canamasas | 이사 | 2023년 6월 20일 A | — | 0 | 0 | $0 |
| Jack Nielsen | 이사 | 2023년 6월 20일 A | — | 0 | 0 | $0 |
| Graham Walmsley | 이사 | 2021년 6월 11일 A | 995,000 | 0 | 0 | $0 |
| Corey S Goodman | — | 2026년 2월 2일 P | 8,453,038 | 1 | 0 | $4,999,999 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| LSV Associates, LLC, Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates II, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., Michael A Carusi, Jean George, Henry A. Plain Jr | 2026년 5월 27일 | 2.20% | 수정본 | — | SEC |
| venBio Global Strategic Fund, L.P., venBio Global Strategic Fund II L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP II, L.P., venBio Global Strategic GP, Ltd., venBio Global Strategic GP II, Ltd., Adelman Robert J, GOODMAN COREY S ×2 제출 서류 | 2026년 2월 4일 | 10.00% | 수정본 | — | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., LSV Associates II, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×3 제출 서류 | 2024년 2월 14일 | — | 최초 제출 | — | SEC |
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities Fund I LP, Logos Opportunities GP LLC, Logos GP LLC ×2 제출 서류 | 2021년 6월 15일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 11 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.55% | 58,924 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.05% | 368,867 SH | 2026년 8월 8일 | 일간 |
| IWO · iShares Trust | 0.01% | 988,668 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 623,766 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 116,302 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.01% | 2,546,108 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 35,651 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 7,659 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,226,065 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,642,854 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9,161 SH | 2026년 8월 8일 | 일간 |